# Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal

> **NCT01404000** · PHASE2 · COMPLETED · sponsor: **PharmaLundensis AB** · enrollment: 40 (actual)

## Conditions studied

- Chronic Obstructive Lung Disease

## Interventions

- **DRUG:** Iodinated Active Charcoal (IodoCarb)

## Key facts

- **NCT ID:** NCT01404000
- **Lead sponsor:** PharmaLundensis AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01404000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01404000, "Treatment of Chronic Obstructive Pulmonary Disease (COPD) With Iodinated Activated Charcoal". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01404000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*